<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="64195">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02270203</url>
  </required_header>
  <id_info>
    <org_study_id>300244</org_study_id>
    <nct_id>NCT02270203</nct_id>
  </id_info>
  <brief_title>LOIS: Long-Term Follow-Up in INSITE/SIFI</brief_title>
  <acronym>LOIS</acronym>
  <official_title>LOIS: Long-Term Follow-Up in INSITE/SIFI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SI-BONE, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>SI-BONE, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the long term safety and effectiveness of SI joint
      fusion using the iFuse Implant System in patients with degenerative sacroiliitis (DS) and/or
      sacroiliac joint disruptions (SD).

      Study Design: This study is extended follow-up from two ongoing multicenter prospective US
      clinical trials. All participants have already undergone the surgical procedure of interest
      (SI joint fusion with iFuse Implant System). The two ongoing trials are:

        -  SIFI:( Sacroiliac Joint Fusion with iFuse Implant System) a single-arm trial of
           patients with degenerative sacroiliitis or sacroiliac joint disruption who underwent
           iFuse placement, and

        -  INSITE(Investigation of Sacroiliac Fusion Treatment):

      a randomized clinical trial of the same patient population who underwent either non-surgical
      treatment or iFuse placement
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>VAS (Visual Analog Scale)</measure>
    <time_frame>3 years on LOIS (5 years post-op)</time_frame>
    <description>improvement in VAS (Visual Analog Scale), Sacroiliac (SI) joint joint pain by â‰¥20 mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Absence of device-related SAE (Serious Adverse Events)</measure>
    <time_frame>3 years on LOIS (5 years post-op)</time_frame>
    <description>Absence of device-related SAE (Serious Adverse Events)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Absence of neurological worsening</measure>
    <time_frame>3 years on LOIS (5 years post-op)</time_frame>
    <description>Absence of neurological worsening.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Absence of surgical re-intervention on the target SI joint</measure>
    <time_frame>3 years on LOIS (5 years post-op)</time_frame>
    <description>Absence of surgical re-intervention on the target SI joint(s)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>VAS (Visual Analog Scale)</measure>
    <time_frame>3 years on LOIS</time_frame>
    <description>Improvement in VAS (Visual Analog Scale), SI joint pain at follow-up visits.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oswestry Disability Index (ODI) Questionnaire</measure>
    <time_frame>3 years on LOIS</time_frame>
    <description>Improvement in Oswestry Disability Index (ODI) at follow-up visits.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement in quality of life (QOL)</measure>
    <time_frame>3 years on LOIS</time_frame>
    <description>Improvement in quality of life as measure by EQ-5D Questionnaire at follow-up visits.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>non-working subjects returning to work</measure>
    <time_frame>3 years on LOIS</time_frame>
    <description>Proportion of non-working subjects who return to work</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CT scans showing bridging bone</measure>
    <time_frame>3 years on LOIS (5 years post-op)</time_frame>
    <description>Proportion of CT scans that show bridging bone across the SI joint at 5 years post-operatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SAE (Serious Adverse Events) occurrence rate</measure>
    <time_frame>3 years on LOIS</time_frame>
    <description>Occurrence rate of serious adverse events.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Patient Satisfaction</measure>
    <time_frame>3 years on LOIS</time_frame>
    <description>Patient Satisfaction Questionnaire. At clinic follow up visits, the subject will complete a brief questionnaire rating satisfaction with iFuse result and whether the subject would undergo iFuse treatment again.</description>
  </other_outcome>
  <other_outcome>
    <measure>Zung Self-Rating Depression Scale (SDS)</measure>
    <time_frame>3 years on LOIS</time_frame>
    <description>At clinic follow-up visits subjects will complete a brief questionnaire developed to characterize a patient's level of depression. It is a 20-item multiple-response questionnaire that assesses depressive symptoms.Analysis of depression scores and medications for depression.</description>
  </other_outcome>
  <other_outcome>
    <measure>Denver SI Joint Questionnaire (DSIJQ)</measure>
    <time_frame>3 years on LOIS</time_frame>
    <description>At clinic follow-up visits subjects will complete a brief questionnaire developed to address sacroiliac joint (SI joint) related dysfunction. Analysis of the Denver SI Joint Questionnaire data as a specific measure of SI joint related disability.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">225</enrollment>
  <condition>Degenerative Sacroilitis</condition>
  <condition>Sacroiliac Joint Disruption</condition>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Pelvic CT at 5 years post-op</intervention_name>
    <description>Pelvic CT at 5 years post-op</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with degenerative sacroiliitis or sacroiliac joint disruption who underwent iFuse
        placement.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient enrolled and treated in SIFI or patient initially randomized to iFuse and
             treated in INSITE. Note: Patient may be in the initial follow up period associated
             with SIFI or INSITE at the same time they consent for this study and &quot;extend&quot; their
             post-operative follow up.

          2. Patient has signed study-specific LOIS informed consent form.

          3. Patient has the necessary mental capacity to participate and is physically able to
             comply with study protocol requirements.

        Exclusion Criteria:

          1. Treated with iFuse as a &quot;crossover&quot; in INSITE.

          2. Currently pregnant or planning pregnancy within 5 years of iFuse Implant.

          3. Patient is a prisoner or a ward of the state.

          4. Known or suspected active drug or alcohol abuse.

          5. Inadequately treated psychiatric illness (e.g., schizophrenia, major depression,
             personality disorders) that could interfere with study participation.

          6. Unwilling to perform the long-term follow up requirements of this study.

          7. Patient has any condition that could substantially prevent long-term follow-up.

          8. Unwilling to return to site at pre-specified study visits.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kathryn Wine, MPH</last_name>
    <phone>408-207-0700</phone>
    <phone_ext>2215</phone_ext>
    <email>kwine@si-bone.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Daniel Cher, MD</last_name>
    <phone>408-207-0700</phone>
    <phone_ext>2233</phone_ext>
    <email>dcher@si-bone.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Yale University School of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bethany Samperi</last_name>
      <phone>203-737-8356</phone>
      <email>bethany.samperi@yale.edu</email>
    </contact>
    <investigator>
      <last_name>Peter Whang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Regenerative Orthopaedics and Spine Institute</name>
      <address>
        <city>Stockbridge</city>
        <state>Georgia</state>
        <zip>30281</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Terry Price</last_name>
      <phone>404-234-8716</phone>
      <email>terrellprice@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Philip Ploska, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Orthopaedic Center of Southern Illinois</name>
      <address>
        <city>Mt. Vernon,</city>
        <state>Illinois</state>
        <zip>62864</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristy Buchanan</last_name>
      <phone>618-242-3778</phone>
      <phone_ext>7176</phone_ext>
      <email>cristyb@OCOSI.ORG</email>
    </contact>
    <investigator>
      <last_name>Don A Kovalsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bluegrass Orthopaedics &amp; Hand Care</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40509</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elaine Wilhite</last_name>
      <phone>859-422-4552</phone>
      <email>eschuwilhite@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Harry Lockstadt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia Orthopaedic Group</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Vogt</last_name>
      <phone>573-443-2402</phone>
      <phone_ext>4391</phone_ext>
      <email>m.vogt@columbiaorthogroup.com</email>
    </contact>
    <investigator>
      <last_name>S. Craig Meyer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Orthopedic and Reconstructive Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie White</last_name>
      <phone>405-702-4440</phone>
      <email>jwhite@medicalresearchintl.com</email>
    </contact>
    <contact_backup>
      <last_name>Kallena Haynes</last_name>
      <phone>405-702-4440</phone>
      <email>Khaynes@medicalresearchintl.com</email>
    </contact_backup>
    <investigator>
      <last_name>Cheng-Lun Soo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Allegheny General Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matt Yeager</last_name>
      <phone>412-359-4272</phone>
      <email>myeager@wpahs.org</email>
    </contact>
    <investigator>
      <last_name>Michael Oh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MUSC</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monica Baczko, MPA</last_name>
      <phone>843-792-8169</phone>
      <email>baczko@musc.edu</email>
    </contact>
    <investigator>
      <last_name>Emily Darr, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Glaser, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Precision Spine Care</name>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <zip>75701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Overlake Hospital Medical Center</name>
      <address>
        <city>Bellevue</city>
        <state>Washington</state>
        <zip>98004</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Midwest Orthopedic Specialty Hospital</name>
      <address>
        <city>Franklin</city>
        <state>Wisconsin</state>
        <zip>53132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tracy Mente, BSN</last_name>
      <phone>414-259-7327</phone>
      <email>Tracy.Mente@wfhc.org</email>
    </contact>
    <investigator>
      <last_name>Clay J Frank, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aurora Research Institute</name>
      <address>
        <city>Green Bay</city>
        <state>Wisconsin</state>
        <zip>54311</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Taylor Romdenne</last_name>
      <phone>920-288-3127</phone>
      <email>taylor.romdenne@aurorabaycare.com</email>
    </contact>
    <investigator>
      <last_name>Robert Limoni, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>August 23, 2016</lastchanged_date>
  <firstreceived_date>October 16, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>si joint</keyword>
  <keyword>si joint injury</keyword>
  <keyword>si joint treatment</keyword>
  <keyword>si joint inflammation</keyword>
  <keyword>si joint problems</keyword>
  <keyword>si joint symptoms</keyword>
  <keyword>hypermobile joint</keyword>
  <keyword>si joint arthritis</keyword>
  <keyword>si joint pain treatment</keyword>
  <keyword>inflamed si joint</keyword>
  <keyword>si joint sclerosis</keyword>
  <keyword>locked si joint</keyword>
  <keyword>si joint injuries</keyword>
  <keyword>si joint disease</keyword>
  <keyword>si joint infection</keyword>
  <keyword>sacroiliac joint pelvic pain</keyword>
  <keyword>sacroiliac joint arthritis treatment</keyword>
  <keyword>si joint pain</keyword>
  <keyword>si joint injections</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
